May 02, 2019

Merrill Insight | Healthcare M&A Spotlight

Healthcare encompasses a multitude of ecosystems, from drug development to digital health to health services. Though each sub-sector remains unique, common drivers, headwinds and due diligence best practices define activity across the industry.

What common DNA threads are savvy dealmakers tracking? 

In this video, watch a cross-section of healthcare M&A specialists discuss big picture trends and due diligence issues impacting the industry today. Answer polls on hot topics and benchmark yourself against your peers in real-time. 

Our panelists:

  • Andrew Kaplan, Principal, Bain Capital Private Equity 
  • Kelly Gold, Vice President, Corporate Development & Finance, CAMP4
  • Christopher French, Managing Director, CG / Petsky Prunier

This is your chance to take a quick reset and test current thinking against your peers. 

Sign up and join us for this relevant and vital conversation.

You may also like:

As the tide turns, what’s next? H2 2022 Market Outlook

Join Datasite as we unpack insights and trends from our global M&A report in partnership with PitchBook. In this on-demand webinar, Datasite and PitchBook will host a panel of M&A leaders to unearth their H2 2022 market outlook, challenges, opportunities, and best practices amid a pivotal year.

Investment banker runs along a beach
M&A Deal Momentum: Influence of ESG on APAC Dealmaking

In the webinar, we will take a deep dive into to the fast-evolving and profoundly important area of ESG in APAC, analyzing the extent to which it is driving and transforming dealmaking in the region, which sectors are being impacted most, and what role technology is playing in diligence to execution.

Democratization of private equity

The emergence of retail investor/public investor money coming into private equity and several investment platforms are really starting to ‘democratize’ access to private equity. Is this connected with the growing number of IPOs that we are seeing for PE firms?